Nephroprotection and chemotherapy sensitivity impact of metformin during cisplatin therapy; an updated review
Chemotherapy has been accepted as the most common choice for cancer treatment. However, chemotherapy-induced toxicity and chemotherapy resistance are the two challenging barriers to the treatment. Metformin is a safe, inexpensive, and the first line drug to treat type II diabetes. It has also a sign...
Saved in:
Main Authors: | Mohsen Akhavan Sepahi (Author), Sarvenaz Mehrabi (Author), Rohollah Valizadeh (Author), Steven James Kellner (Author), Azin Mirzazadeh (Author), Semko Ebrahimi (Author) |
---|---|
Format: | Book |
Published: |
Society of Diabetic Nephropathy Prevention,
2019-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Administration of metformin in type 2 diabetes mellitus patients with chronic kidney disease; facts and myths
by: Mohsen Akhavan Sepahi, et al.
Published: (2020) -
Intravenous contrast agents in diabetic patients taking metformin; an updated review on current concepts
by: Masoumeh Asgharpour, et al.
Published: (2020) -
Comparative effect of curcumin and nanocurcumin on nephroprotection at cisplatin-induced rats
by: Ni Made D Sandhiutami, et al.
Published: (2019) -
Nephroprotective Effects of Benzyl Isothiocyanate and Resveratrol Against Cisplatin-Induced Oxidative Stress and Inflammation
by: Abdelazim Ibrahim, et al.
Published: (2018) -
Evaluation of nephroprotective and immunomodulatory activities of antioxidants in combination with cisplatin against murine visceral leishmaniasis.
by: Meenakshi Sharma, et al.
Published: (2012)